文献速递其他结缔组织病

系统性硬化症中的抗波形蛋白抗体:与胃排空缓慢及肠外临床表型的关联

Antivinculin Antibodies in Systemic Sclerosis: Associations With Slow Gastric Transit and Extraintestinal Clinical Phenotype.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2023-05-06

在88例伴有胃肠道疾病的系统性硬化症(SSc)患者中,23%检出抗波形蛋白抗体。该抗体与胃排空缓慢、局限性皮肤型及甲状腺疾病正相关,与Medsger严重度评分≥2的肺部受累负相关,多变量模型仍显著。

要点

  • 88例SSc伴胃肠道病患者中20例(23%)抗波形蛋白抗体阳性。
  • 抗体阳性者胃排空缓慢比例35% vs 22%,多变量模型仍与胃排空缓慢显著相关。
  • 抗体阳性与局限性皮肤型(OR 9.60)和甲状腺病(OR 4.09)正相关,与肺部受累(OR 0.25)负相关。

核心结论

  • 抗波形蛋白抗体与SSc患者胃排空缓慢相关,可能为理解SSc胃肠道并发症提供线索。

研究设计与样本

  • 对88例特征明确的SSc合并胃肠道疾病患者,用酶联免疫吸附法检测抗波形蛋白抗体,比较有无抗体患者的全肠道闪烁显像、胃肠道症状评分及SSc临床特征。

主要发现

  • 88例中20例(23%)有抗波形蛋白抗体,胃排空缓慢者中抗体阳性率35% vs 22%。
  • 单变量分析:抗体阳性者更常见局限性皮肤型(OR 9.60 [95%CI 1.19, 77.23])和甲状腺疾病(OR 4.09 [95%CI 1.27, 13.21])。
  • 抗体阳性者Medsger严重度评分≥2的肺部受累较少(OR 0.25 [95%CI 0.07, 0.92])。
  • 抗体水平越高胃排空越慢(β系数 -3.41 [95%CI -6.72, -0.09])。
  • 多变量模型中上述关联仍显著;抗体存在(β系数 -6.20 [95%CI -12.33, -0.063])和抗体水平较高(β系数 -3.64 [95%CI -7.05, -0.23])均与胃排空缓慢显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The gastrointestinal (GI) tract is commonly affected in systemic sclerosis (SSc). A positive association between antivinculin antibody levels and GI symptom severity is reported in SSc. We sought to examine whether antivinculin antibodies associate with measures of GI dysmotility and extraintestinal clinical phenotype in SSc. METHODS: A total of 88 well-characterized patients with SSc and GI disease were assayed for antivinculin antibodies by enzyme-linked immunosorbent assay. Whole-gut scintigraphy, GI symptom scores, and clinical features of SSc were compared between patients with and without antibodies. RESULTS: Twenty of 88 (23%) patients had antivinculin antibodies, which were more prevalent in patients with slow gastric transit (35% versus 22%). In the univariate analyses, patients who were positive for antivinculin antibodies were more likely to have limited cutaneous disease (odds ratio [OR] 9.60 [95% confidence interval (95% CI) 1.19, 77.23]) and thyroid disease (OR 4.09 [95% CI 1.27, 13.21]). Such patients were also less likely to have lung involvement based on a Medsger Severity Score of ≥2 (OR 0.25 [95% CI 0.07, 0.92]). Higher levels of antivinculin autoantibodies were associated with less gastric emptying (β coefficient -3.41 [95% CI -6.72, -0.09]). The association between antivinculin antibodies and each of these clinical features remained significant in the multivariable model. In particular, the presence of antivinculin antibodies (β coefficient -6.20 [95% CI -12.33, -0.063]) and higher levels of antivinculin antibodies (β coefficient -3.64 [95% CI -7.05, -0.23]) were each significantly associated with slower gastric transit. CONCLUSION: Antivinculin antibodies associate with slower gastric transit in SSc and may provide insight into GI complications of SSc.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Herrán M, Adler BL, Perin J, et al. Antivinculin Antibodies in Systemic Sclerosis: Associations With Slow Gastric Transit and Extraintestinal Clinical Phenotype. Arthritis Care Res (Hoboken). 2023. PMID: 36951252. doi:10.1002/acr.25118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。